Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1

Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1

Abstract Background Neonatal hypoxic-ischemic brain damage, characterized by tissue loss and neurologic dysfunction, is a leading cause of mortality and a devastating disease of the central nervous system. We have previously shown that vitexin has been attributed various medicinal properties and has...

Full description

Bibliographic Details
Main Authors: Wen-di Luo, Jia-wei Min, Wen-Xian Huang, Xin Wang, Yuan-yuan Peng, Song Han, Jun Yin, Wan-Hong Liu, Xiao-Hua He, Bi-Wen Peng
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Journal of Neuroinflammation
Subjects:
HIBD
Vitexin
NKCC1
F-actin
Blood-brain barrier
Inflammation
Online Access:http://link.springer.com/article/10.1186/s12974-018-1221-6

Internet

http://link.springer.com/article/10.1186/s12974-018-1221-6

Similar Items